The data center, called Project Kilby, is expected to consume nearly 2.7 gigawatts of electricity, equivalent to about 2 million homes. A majority of the electricity will come from large gas turbines ...

Tesla used dubious safety stats to make case for FSD approval in Europe Automaker's crash data has been called into question by researchers Sweden says regulators 'look beyond headline figures' to ...

Just when you thought the AI data center boom couldn’t get any crazier, Meta has gone and built data centers in tents. The strategy appears to borrow in equal parts from Tesla and xAI. In a bid to cut ...

Overall Study Population Achieved ORR of 70.8% and DCR of 100.0%; Responses Consistent Across Ivonescimab Dose Levels Combined with Chemotherapy Acceptable and Manageable Safety Profile for ...

“If you are a mathematician,” one of the world’s leading mathematicians recently wrote, “you may want to make sure you are sitting down before reading further.” And you’ll definitely need to sit down ...

The tech giant says a breakthrough in data center networking has dramatically accelerated the flow of information through its massive cloud infrastructure. The new technology hinges on a “quasi-random ...

The frequency of natural disasters is increasing, and hence disaster responders are called on more than ever before. During disaster response, the focus of health and well-being is typically on the ...

AgenusInc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced new retrospective data showing that Noetik’s artificial intelligence-based TARIO-2 model identified spatial tumor ...

On a Saturday morning, you head to the hardware store. Your neighbors’ Ring cameras film your walk to the car. Your car’s sensors, cameras and microphones record your speed, how you drive, where ...

The Food and Drug Administration is asking Eli Lilly to gather more safety data on its new weight loss pill, Foundayo, including whether it could be linked to liver and heart problems, according to ...

SOUTH SAN FRANCISCO, Calif., & PRINCETON, N.J.--(BUSINESS WIRE)--Kardigan™, a clinical-stage precision therapeutics company developing medicines that target the root cause of specific cardiovascular ...